Prevalence, persistence and clinical correlations of classic and novel antiphospholipid antibodies in systemic lupus erythematosus

Marchetti, Tess; Ribi, Camillo; Perneger, Thomas; Trendelenburg, Marten; Huynh-Do, Uyen; De Moerloose, Philippe; Chizzolini, Carlo

doi:10.1093/rheumatology/key095

Scientific article

English

Prevalence, persistence and clinical correlations of classic and novel antiphospholipid antibodies in systemic lupus erythematosus

ContributorsMarchetti, Tess; Ribi, Camillo; Perneger, Thomas; Trendelenburg, Marten; Huynh-Do, Uyen; De Moerloose, Philippe; Chizzolini, Carlo

Published inRheumatology, vol. 57, no. 8, p. 1350-1357

Publication date2018

Abstract

aPL are frequently present in SLE. In a well characterized SLE cohort we aimed at investigating the prevalence of aPL and assessing their analytical performance and clinical association by testing criteria specificities including LA, aCL IgG and IgM, anti-β2-glycoprotein 1 (antiβ2GP1) IgG and IgM, as well as the non-criteria aPS-PT IgG and IgM and anti-β2GP1 domain 1 (aD1) IgG.

Affiliation entities

Research groups

Citation (ISO format)

MARCHETTI, Tess et al. Prevalence, persistence and clinical correlations of classic and novel antiphospholipid antibodies in systemic lupus erythematosus. In: Rheumatology, 2018, vol. 57, n° 8, p. 1350–1357. doi: 10.1093/rheumatology/key095

Article (Published version)

Identifiers

PID : unige:106807
DOI : 10.1093/rheumatology/key095
PMID : 29672737

Journal ISSN1462-0324

400views

1downloads

Creation09/07/2018 16:47:00

First validation09/07/2018 16:47:00

Update15/03/2023 08:28:36

Status update15/03/2023 08:28:36

Last indexation31/10/2024 10:47:08

Archive ouverte UNIGE

Prevalence, persistence and clinical correlations of classic and novel antiphospholipid antibodies in systemic lupus erythematosus

Technical informations